Personalized Medicine Company Iggbo Closes $13M Series A Financing

iggboIggbo, a Richmond, VA-based personalized medicine company, closed a $13m Series A financing round.

The round was led by Heritage Group.

The company will use the funds to expand operations.

Co-founded in 2015 by Mark Van Roekel, President, Nuno Valentine, Chief Executive Officer, and Dr. Shaiv Kapadia, Chief Medical Officer, Iggbo is a healthcare technology company focused on bringing personalized medicine to more people through on-demand blood draws and medical testing. The Iggbo network consists of over 8,000 phlebotomists who perform fixed and on-demand blood draws at a convenient location, chosen by the patient and their healthcare provider. Once an appointment has been set at the patient’s desired location, a series of reminders take place – email, text, and automated phone calls – to ensure appointments are not missed. Every sample is monitored, tracked, and connected digitally.
The company currently operates in over 120 cities offering its on-demand blood collection services to diagnostic laboratories, health systems, providers, retailers, and payers.



Join the discussion